Futura Medical (LON:FUM) Trading Down 15.8% – Here’s What Happened

Posted by on Sep 3rd, 2026

Futura Medical plc (LON:FUM – Get Free Report) shares traded down 15.8% during mid-day trading on Thursday . The company traded as low as GBX 0.20 and last traded at GBX 0.28. Approximately 18,645,404 shares traded hands during trading, an increase of 102% from the average daily volume of 9,214,374 shares. The stock had previously closed at GBX 0.33.

Futura Medical Stock Down 15.8%

The firm has a 50-day moving average of GBX 0.42 and a 200 day moving average of GBX 0.78. The stock has a market capitalization of £1.62 million, a P/E ratio of -0.10 and a beta of 0.02.

Futura Medical (LON:FUM – Get Free Report) last announced its quarterly earnings results on Tuesday, September 1st. The company reported GBX (0.20) earnings per share (EPS) for the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. Analysts predict that Futura Medical plc will post 2.8486672 EPS for the current fiscal year.

About Futura Medical

(Get Free Report)

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.

Further Reading

Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.